Skip to main content
. 2022 Jan 27;122(1):197–202. doi: 10.1007/s13760-022-01874-8

Table 3.

Evolution over time in the 11 patients of the DBS group who completed the study

Pre-operatively meds only 6 months 6 years 12 years Difference pre-op—6 months Difference pre-op—12 years
Best UPDRS III on meds, on DBS 17 ± 8.2 17.5 ± 5.6 21.3 ± 7.8 24.2 ± 11.2 p = 0.92 p = 0.17
Worst UPDRS III on meds, on DBS 54 ± 9.92 28.8 ± 7.3 31.1 ± 8.3 62 ± 13.1 p = 0.01 p = 0.92
LEDD mg 1032 ± 144 483 ± 86 552 ± 76 655 ± 132 p < 0.001 p = 0.01

Significant differences in bold, two-tailed ANOVA + post hoc Bonferroni corrections for repeated time measurements. See text for details of patients’ conditions